Autorisation d’accès précoce refusée à la spécialité ZURZUVAE (zuranolone) dans l'indication « traitement de la dépression sévère du post-partum (DPP) suivant l’accouchement chez les adultes. »
See also
HAS opinions and decisions
23/06/2025
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
kFAV64eGsupx5aYY
